MedPath
HSA Approval

METHOTREXATE REMEDICA FILM-COATED TABLET 2.5MG

SIN17136P

METHOTREXATE REMEDICA FILM-COATED TABLET 2.5MG

METHOTREXATE REMEDICA FILM-COATED TABLET 2.5MG

November 12, 2024

GOLDPLUS UNIVERSAL PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantGOLDPLUS UNIVERSAL PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET, FILM COATED

ORAL

Medical Information

L04AX03

Manufacturer Information

GOLDPLUS UNIVERSAL PTE LTD

REMEDICA LTD (BUILDING 10-ANTINEOPLASTIC AND IMMUNOMODULATING PRODUCTS)

Active Ingredients

Methotrexate

2.50mg

Methotrexate

Documents

Package Inserts

Methotrexate Remedica 2.5mg Tablet PI.pdf

Approved: November 12, 2024

Download

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.